-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on LB Pharmaceuticals, Raises Price Target to $60

Benzinga·08/24/2026 10:06:23
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains LB Pharmaceuticals (NASDAQ:LBRX) with a Buy and raises the price target from $45 to $60.